Cook Steven L. sold $7K of OMDA

Cook Steven L. (Chief Financial Officer) sold 300 shares of Omada Health, Inc. (OMDA) at $22.00 on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jul 2, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings, but it does not introduce new company fundamentals or policy changes.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation and small transaction size reduce expected market impact.

03

What to watch

The dollar amount is relatively small and the filing does not include any new operational or financial guidance, so traders may treat it as routine compliance rather than a catalyst.

Relevance 2/10Novelty 3/10Timing: filed July 2, 2026 after-hours/late session disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc. (OMDA).

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven L. Cook filed a Form 4 open-market sale of 300 shares at $22.00 on June 30 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move based solely on this Form 4 sale.

Evidence & confidence

The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, but the explicit 10b5-1 pre-arrangement makes that interpretation less compelling.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Steven L. Cook

    Chief Financial Officer who sold 300 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.